Претраживање
Приказ резултата 11-20 од 44
Kontrola finalnog stadijuma imunski posredovanog dijabetesa pomoću antagonista faktora inhibicije migracije makrofaga (S,R)-3-(4-hidroksifenil)-4,5-dihidro-5-izoksazol metil estra sirćetne kiseline / Control of the of the final stage of immune-mediated diabetes by ISO-1, an antagonist of macrophage migration inhibitory factor
(Belgrade: Serbian Biological Society, 2008)
Immunosuppressive and anti-inflammatory action of antioxidants in rat autoimmune diabetes
(Journal of Autoimmunity, 2004)
MIF antagonists are anti-diabetogenic.
(Abstracts of Papers of the American Chemical Society, 2004)
Antidiabetogenic effect of mycophenolate mofetil is associated with down-regulation of adhesive interactions and autoreactive cell activation
(Immunology of Diabetes: Autoimmune Mechanisms and the Prevention and Cure of Type 1 Diabetes, 2002)
Macrophage migration inhibitory factor as potential therapeutic target for prevention and treatment of autoimmune diabetogenesis. Lessons from animal models
(International Journal of Molecular Medicine, 2009)
Therapeutic effects of combined treatment with ribavirin and tiazofurin on experimental autoimmune encephalomyelitis development: Clinical and histopathological evaluation
(New York, USA: Springer - Plenum publishers, 2008)
Interleukin-17 stimulates inducible nitric oxide synthase-dependent toxicity in mouse beta cells
(Cellular and Molecular Life Sciences, 2005)